Biomedicines (Nov 2022)

Mitochondrial Ca<sup>2+</sup> Signaling and Bioenergetics in Alzheimer’s Disease

  • Nikita Arnst,
  • Nelly Redolfi,
  • Annamaria Lia,
  • Martina Bedetta,
  • Elisa Greotti,
  • Paola Pizzo

DOI
https://doi.org/10.3390/biomedicines10123025
Journal volume & issue
Vol. 10, no. 12
p. 3025

Abstract

Read online

Alzheimer’s disease (AD) is a hereditary and sporadic neurodegenerative illness defined by the gradual and cumulative loss of neurons in specific brain areas. The processes that cause AD are still under investigation and there are no available therapies to halt it. Current progress puts at the forefront the “calcium (Ca2+) hypothesis” as a key AD pathogenic pathway, impacting neuronal, astrocyte and microglial function. In this review, we focused on mitochondrial Ca2+ alterations in AD, their causes and bioenergetic consequences in neuronal and glial cells, summarizing the possible mechanisms linking detrimental mitochondrial Ca2+ signals to neuronal death in different experimental AD models.

Keywords